Nelson, Van Denburg & Campbell Wealth Management Group, LLC Vor Biopharma Inc. Transaction History

Nelson, Van Denburg & Campbell Wealth Management Group, LLC

$2.42 Billion
Q3 2024

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 Apr 30, 2024	BUY	$1.8 - $2.85 $10 - $17	6 New	6 $0

Others Institutions Holding VOR

# of Institutions

Shares Held

41.2M

Call Options Held

9.3K

Put Options Held

100

Ra Capital Management, L.P. Boston, MA

22.7M
Shares

$19.6 Million
0.22% of portfolio
5 Am Venture Management, LLC San Francisco, CA

6.36M
Shares

$5.47 Million
1.77% of portfolio
Hudson Bay Capital Management LP Greenwich, CT

2.47M
Shares

$2.12 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

1.95M
Shares

$1.68 Million
0.0% of portfolio
Cowen And Company, LLC

1.22M
Shares

$1.05 Million
0.02% of portfolio

View Full List

About Vor Biopharma Inc.

Ticker VOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,056,300
Market Cap $32.7M
Description
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...

More about VOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nelson, Van Denburg & Campbell Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nelson, Van Denburg & Campbell Wealth Management Group, LLC with notifications on news.

Account